We also measured the expression of PIK3CB in FTI-treated fibroblasts from subjects with HGPS and unaffected controls, as this was the only gene identified by microarray analyses to be differentially expressed between these experimental groups. The gene discussed is PIK3CB; the disease is Hutchinson-Gilford progeria syndrome.